Industry Insights

41. Cell Line Development: Research Cell Banks In 5 Months 3/27/2025

    By leveraging cutting-edge technologies and refined methodologies, see how researchers can streamline cell line development, enhancing both productivity and scalability.

42. A Roadmap For Navigating Biologic Development 1/21/2026

    A phase‑appropriate roadmap guides biologics from early formulation to commercialization through Quality by Design, strong analytics, stability optimization, and regulatory alignment.

43. ADC Executive Roundtable — Exploring Linker Technology 8/7/2023

    A linker doesn't just act like a trailer hitch for antibody-drug conjugates. It's more like the driver steering the protein and payload toward the target, protecting it along the way. In the second and final part of a Q&A series, three biotech CEOs unpack exciting developments in ADC linker technology.

44. Simplifying The Bioprocessing 4.0 Journey 10/26/2021

    With a practical step-wise approach starting with PAT, plug and play/industry-standard interfaces, data analytics, and improved controls for CPP monitoring, Bioprocessing 4.0 is achievable.

45. Navigating The Pros And Cons In Annex 1's PUPSIT Requirements 7/12/2023

    Annex 1 made Pre-use Post Sterilization Integrity Testing, or PUPSIT, a requirement, and enforcement has begun in earnest over the last few years. This article digs into the problems that downstream filter manipulation can cause and questions whether the risks outweigh any benefits.

46. Project Management: The Secret Weapon In Effective Tech Transfer 5/23/2024

    Explore how a CMO with innovative practices and a successful approach to tech transfer and manufacturing processes can help meet project timelines and mitigate risk on the path to market.

47. Four Questions To Ask Before Implementing Data Quality Software 8/6/2023

    Ensuring high data quality by using data quality software to implement and enforce data quality rules.

48. Genomics & Tissue Phenomics: Taking A Dual Approach To Drug Development 6/9/2015

    It can be said that 2014 was the year of genomics. The industry saw several new startups in the area, and Google's venture into the genomics market made a big splash. However, in 2015 the industry is expected to look beyond genes and focus on a dual approach to drug development leveraging data from both the genes and the tissue, particularly in oncology.

49. A Brief Overview Of Vaccine Purification Technologies And Analytical Tools 3/23/2023

    Downstream processing remains a major bottleneck for vaccine production, and the industry is racing to develop new purification technologies. Here's a snapshot of where we stand and of what needs to happen next to increase quality and yields.

50. Why Is Pharma Resistant To Digitization? 11/22/2021

    Digitizing what basically amounts to a ruled notebook into an electronic solution sounds like an easy win. It’s when you start to dig deeper that this task can quickly become burdensome, especially when presenting the proposed process map and data workflow to a steering committee.